FDA review finds naproxen safer for heart than other NSAIDs

01/30/2014 | Medscape (free registration)

FDA reviewers said study data appear to show naproxen does not carry the cardiovascular risks that other nonsteroidal anti-inflammatory drugs do, and the FDA may consider revising the label warning for the drug. All NSAID drugs got boxed warnings in 2005 indicating cardiovascular risks.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA